menu Search
Kohagra

Kohagra

sildenafil

Manufacturer:

Centurion Lab

Distributor:

Tobie Pharma
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Sildenafil citrate
Indications/Uses
Management of erectile dysfunction & pulmonary arterial HTN.
Click to view Kohagra detailed prescribing information
Dosage/Direction for Use
50 mg approx 1 hr before sexual activity, may be increased to 100 mg or decreased to 25 mg. Max recommended dose & dosing frequency: 100 mg once daily.
Click to view Kohagra detailed prescribing information
Overdosage
View Kohagra overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Not indicated for use in women. Co-administration w/ nitric oxide donors or nitrates in any form.
Click to view Kohagra detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Kohagra detailed prescribing information
Special Precautions
Potential cardiac risk for sexual activity in patients w/ pre-existing CV disease; who have suffered MI, stroke or life-threatening arrhythmia w/in last mth; w/ resting hypotension (BP <90/50) or HTN (BP >170/110); cardiac failure or CAD causing unstable angina; retinitis pigmentosa. Care in patients w/ anatomical deformation of penis or haematological disorders that may predispose to priapism. Patients who experience dizziness or visual disturbances should not drive or operate machine. Patients w/ hepatic or severe renal impairment.
Click to view Kohagra detailed prescribing information
Adverse Reactions
Headache, flushing, dyspepsia. Visual disturbances (eg, blurred vision, photophobia, chromatopsia, cyanopsia, eye irritation, pain & redness of the eyes); dizziness, insomnia, anxiety, vertigo, epistaxis, nasal congestion, pyrexia, GI disturbances (eg, diarrhea & vomiting); priapism; skin rashes, erythema, alopecia, limb &/or back pain, myalgia, facial oedema, fluid retention, paraesthenia, UTI; dyspnoea, cough, rhinitis, sinusitis, bronchitis & cellulitis.
Click to view Kohagra detailed prescribing information
Drug Interactions
May potentiate hypotensive effects of organic nitrates. May enhance hypotensive effects of nicorandil. Symptomatic hypotension may occur when given w/ α-blockers. Drugs that inhibit cytochrome P450 isoenzyme CYP3A4 (eg, cimetidine, delavirdine, erythromycin, itraconazole & ketoconazole) may reduce PDE5 clearance. Plasma conc are significantly increased by HIV-PIs, & particularly by ritonavir-booster regimens. Grapefruit may increase plasma conc. CYP3A4 inducers (eg, rifampicin) likely to decrease plasma conc.
Click to view Kohagra detailed prescribing information
Storage
View Kohagra storage conditions for details to ensure optimal shelf-life.
Description
View Kohagra description for details of the chemical structure and excipients (inactive components).
Action
View Kohagra mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Drugs for Erectile Dysfunction & Ejaculatory Disorders
ATC Classification
G04BE03 - sildenafil ; Belongs to the class of drugs used in erectile dysfunction.
Regulatory Classification
Rx
Presentation/Packing
Form
Kohagra FC tab 100 mg
Packing/Price
4's (P480/box)
Form
Kohagra FC tab 25 mg
Packing/Price
4's (P172/box)
Form
Kohagra FC tab 50 mg
Packing/Price
4's (P312/box)